Orforglipron for Type 2 Diabetes and Pancreatic Risk Assessment-Reply
JAMA · 2026 Oct 26 · Giorgino F, Ludwig L, Denning M et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 25 20:00 ETSource: JAMA
From the source
Read at pubmed.ncbi.nlm.nih.govOrforglipron for Type 2 Diabetes and Pancreatic Risk Assessment-Reply
JAMA · 2026 Oct 26 · Giorgino F, Ludwig L, Denning M et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42931748/
